Peru Longitudinal Study

March 10, 2021 updated by: David Drozek, Ohio University

Longitudinal Evaluation of Disease Prevalence in Impoverished Communities of Lima, Peru

The purpose of this study is to evaluate the change in disease prevalence over time in impoverished urban communities in Lima, Peru.

Study Overview

Detailed Description

The aim is to track the changes in disease prevalence of people living in impoverished urban communities in Lima over the next 10 years.

Based on data collected in prior years and in an ongoing manner, Ohio University Global Health teams will be introducing interventions focused to positively impact disease states and trends in this population.

The current focus is on chronic lifestyle related diseases and their precursors: cardiovascular disease, hypertension, dyslipidemia, diabetes, and overweight / obesity.

Study Type

Interventional

Enrollment (Actual)

861

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Athens, Ohio, United States, 45701
        • Ohio University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • minors age 12-17 presenting to the free community clinic, with a responsible adult who can give consent; minors will give assent.
  • consenting adults of any age who present to the clinic.

Exclusion Criteria:

  • adults who are unable to give consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lifestyle Intervention
Impoverished communities in Lima, Peru will be offered free medical clinics. Four communities have been chosen initially for focus over the following 10 years. These communities will be made aware of their risk for chronic lifestyle related diseases. In conjunction with the communities, specific interventions focused on a plant-based diet, physical activity, stress management and control of unhealthy habits will be devised.
  1. Community awareness: a) individuals will be made aware of their own chronic lifestyle diseases and risk factors b) communities will be made aware of their aggregated data concerning chronic lifestyle related diseases and risk factors.
  2. Education for individuals and communities on the meaning of the lifestyle diseases and risk factors. a) individual and small group sessions explaining diseases and lifestyle measures that are helpful, b) community level education to tentatively include i) shopping guides and recipes, ii) urban gardening projects, iii) puppet shows and other community presentations, iv) literature and posters.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight
Time Frame: yearly for 10 years
weight in kilograms will be utilized to determine body mass index
yearly for 10 years
Systolic blood pressure
Time Frame: yearly for 10 years
measured with a manual sphygmomanometer in millimeters of mercury
yearly for 10 years
Diastolic Blood Pressure
Time Frame: yearly for 10 years
measured with a manual sphygmomanometer in millimeters of mercury
yearly for 10 years
glycosylated hemoglobin
Time Frame: periodically over 10 years
measured in percent via fingerstick capillary blood and portable analyzer
periodically over 10 years
Total cholesterol
Time Frame: periodically over 10 years
measured in percent via fingerstick capillary blood and portable analyzer
periodically over 10 years
Low-density lipoprotein cholesterol
Time Frame: periodically over 10 years
measured in percent via fingerstick capillary blood and portable analyzer
periodically over 10 years
High density lipoprotein cholesterol
Time Frame: periodically over 10 years
measured in percent via fingerstick capillary blood and portable analyzer
periodically over 10 years
Triglycerides
Time Frame: periodically over 10 years
measured in percent via fingerstick capillary blood and portable analyzer
periodically over 10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Herth Hope Index
Time Frame: yearly for 10 years
validated survey utilized to evaluate level of hope for the future
yearly for 10 years
Household hunger scale
Time Frame: yearly for 10 years
validated survey to measure food insecurity
yearly for 10 years
Patient Health Questionnaire - 4 (PHQ-4)
Time Frame: yearly for 10 years
used to evaluate depression and anxiety
yearly for 10 years
Exercise vital sign
Time Frame: yearly for 10 years
the minutes of exercise during the last week
yearly for 10 years
Perceived Stress Scale
Time Frame: yearly for 10 years
validated survey to evaluate level of stress
yearly for 10 years
24 hour dietary recall
Time Frame: yearly for 10 years
report of all foods consumed in the last 24 hours, which will be utilized to determine the nutritional value of dietary intake
yearly for 10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 5, 2017

Primary Completion (Actual)

October 1, 2019

Study Completion (Actual)

March 1, 2020

Study Registration Dates

First Submitted

November 12, 2018

First Submitted That Met QC Criteria

November 12, 2018

First Posted (Actual)

November 15, 2018

Study Record Updates

Last Update Posted (Actual)

March 15, 2021

Last Update Submitted That Met QC Criteria

March 10, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 17-X-88

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on Lifestyle Modification

Subscribe